BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Policy

  Lawsuits Aim to Kill Onyx Pharmaceuticals, Inc.-Amgen Deal

  September 9, 2013

   · 

  1 min read
• Drug Development

  BioMarin Pharmaceutical Inc. Denies Compassionate Use to Cancer Patient

  September 9, 2013

   · 

  1 min read
• Pfizer Inc.'s Cancer Drug Sutent Linked to Severe Skin Reactions

  September 9, 2013

   · 

  1 min read
• Genome Institute of Singapore Scientists Discover New RNA Processing Pathway Important In Human Embryonic Stem Cells

  September 9, 2013

   · 

  7 min read
• Protea Biosciences, Inc. Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th

  September 9, 2013

   · 

  1 min read
• Pharm Country

  Cancer Genetics, Inc. Announces Upcoming Investor Conference Schedule

  September 9, 2013

   · 

  1 min read
• Business

  Monash University Orders High-End Transmission Electron Microscope From FEI Company for Integrated Structural Biology

  September 9, 2013

   · 

  1 min read
• Business

  NeoStem, Inc. Forms Advisory Group of Experts for Steroid Resistant Asthma

  September 9, 2013

   · 

  1 min read
• Business

  Swedish Orphan Biovitrum Acquires Full Rights for Kineret® and Additional Clinical Data for Kepivance®From Amgen

  September 9, 2013

   · 

  1 min read
• Rhizen Pharmaceuticals S.A. Announces a Scientific Presentation on the PI3K-Delta Inhibitor, TGR-1202, at the XV International Workshop on Chronic Lymphocytic Leukemia at Cologne, Germany

  September 9, 2013

   · 

  1 min read